학술논문
Efficacy and safety of netakimab, anti-il-17a monoclonal antibody, in patients with ankylosing spondylitis. results of phase iii international, multicenter, randomized double-blind clinical trial BCD-085-5/astera
Document Type
Article
Author
Mazurov, V.I.; Gaydukova, I.Z.; Zhugrova, E.S.; Erdes, Sh.; Dubinina, T.V.; Pristrom, A.M.; Kunder, E.V.; Soroka, N.F.; Kastanayan, A.A.; Povarova, T.V.; Plaksina, T.V.; Shesternya, P.A.; Kropotina, T.V.; Antipova, O.V.; Smolyarchuk, E.A.; Tciupa, O.A.; Abdulganieva, D.I.; Lapshina, S.A.; Krechikova, D.G.; Gordeev, I.G.; Nesmeyanova, O.B.; Tyrenko, V.V.; Ilivanova, E.P.; Strelkova, A.V.; Eremeeva, A.V.
Source
In: Nauchno-Prakticheskaya Revmatologiya . (Nauchno-Prakticheskaya Revmatologiya, 2020, 58(4):376-386)
Subject
Language
English
ISSN
19954492
19954484
19954484